PIA
WVE icon

Piedmont Investment Advisors’s Wave Life Sciences WVE Stock Holding History

Piedmont Investment Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-306
Closed -$12K – 2305
2018
Q2 		$12K Buy
+306
New +$13.2K ﹤0.01% 1775

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Piedmont Investment Advisors's WVE Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Wave Life Sciences (WVE) in Q3 2018, closing a stake of 306 shares — an estimated $12K sold.

Piedmont Investment Advisors first reported a position in WVE in Q2 2018 and held it in 1 quarter. The position peaked at $12K in Q2 2018. 92 funds tracked by Wall St. Rank hold WVE as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Wave Life Sciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 306 Wave Life Sciences shares in Q3 2018, an estimated $12K.
  • Piedmont Investment Advisors first reported a position in Wave Life Sciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Wave Life Sciences position peaked at $12K in Q2 2018.
  • 92 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.